Arax Advisory Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $670K | Sell |
|
|||||
|
2025
Q3 | $1.16M | Buy |
|
|||||
|
2025
Q2 | $271K | Sell |
|
|||||
|
2025
Q1 | $454K | Sell |
|
|||||
|
2024
Q4 | $682K | Buy |
|
|||||
|
2024
Q3 | $430K | Sell |
|
|||||
|
2024
Q2 | $519K | Sell |
|
|||||
|
2024
Q1 | $487K | Sell |
|
|||||
|
2023
Q4 | $411K | Buy |
|
|||||
|
2023
Q3 | $208K | Buy |
|
|||||
|
2023
Q2 | $173K | Buy |
|
|||||
|
2023
Q1 | $169K | Buy |
|
|||||
|
2022
Q4 | $131K | Sell |
|
|||||
|
2022
Q3 | $98K | Buy |
|
|||||
|
2022
Q2 | $100K | Buy |
|
|||||
|
2022
Q1 | $60K | Buy |
|
|||||
|
2021
Q4 | $5K | Buy |
|
|||||
|
2021
Q3 | $1K | Buy |
|
|||||
|
2020
Q4 | $8K | Hold |
|
|||||
|
2020
Q3 | $8K | Buy |
|
|||||
|
2020
Q2 | $8K | Buy |
|
|||||
|
2020
Q1 | $7K | Hold |
|
|||||
|
2019
Q4 | $7K | Hold |
|
|||||
|
2019
Q3 | $6K | Hold |
|
|||||
|
2019
Q2 | $6K | Buy |
|
|||||
|
2018
Q4 | $5K | Sell |
|
|||||
|
2018
Q3 | $9K | Sell |
|
|||||
|
2018
Q2 | $62K | Sell |
|
|||||
|
2018
Q1 | $68K | Sell |
|
|||||
|
2017
Q4 | $270K | Buy |
|
|||||
|
2017
Q3 | $242K | Sell |
|
|||||
|
2017
Q2 | $223K | Buy |
|
|||||
|
2017
Q1 | $167K | Buy |
|
|||||
|
2016
Q4 | $125K | Buy |
|